Contrast‐enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: A pictorial essay | Zendy

Sheppard Declan | Zendy; Allan Lynsay | Zendy; Martin Pat | Zendy; McLeay Trudy | Zendy; Milne Wendy | Zendy; Houston J. Graeme | Zendy

Premium

Contrast‐enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: A pictorial essay

Author(s) -

Sheppard Declan,

Allan Lynsay,

Martin Pat,

McLeay Trudy,

Milne Wendy,

Houston J. Graeme

Publication year - 2004

Publication title -

journal of magnetic resonance imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.563

H-Index - 160

eISSN - 1522-2586

pISSN - 1053-1807

DOI - 10.1002/jmri.20114

Subject(s) - cholangiography , magnetic resonance imaging , radiology , medicine , contrast (vision) , t2 weighted , computer science , artificial intelligence

Mangafodipir, a manganese‐containing hepatobiliary contrast agent, is excreted in bile. We review the principles and practice of a contrast‐enhanced MRC technique using mangafodipir and compare it with standard T2‐weighted magnetic resonance cholangiography (MRC) sequences. Potential applications include the evaluation of leaks and strictures; the assessment of drainage in normal, surgically by‐passed, stented and obstructed biliary systems; the diagnosis of cholecystitis; and the evaluation of normal and variant biliary anatomy. J. Magn. Reson. Imaging 2004;20:256–263. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research